Dr. Andrew Lee has the following interests to declare: Amgen (speaker’s bureau), Alexion (speaker’s bureau), Viridian (Advisory Board), Stoke, AstraZeneca, and Bristol Mayers Squibb. The other authors report no conflicts of interest.